Want to join the conversation?
$EBS signed a multi-year contract with the Biomedical Advanced Research and Development Authority, for the advanced development and delivery of NuThrax, $EBS' next generation anthrax vaccine candidate. The contract is valued at up to approx. $1.6Bil & consists of a 5-year base period of performance valued at approx. $200MM to develop NuThrax.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?